News
EQS-Adhoc: innoscripta SE publishes Guidance for 2026
EQS-Adhoc: innoscripta SE publishes Guidance for 2026
EQS-News: Steyr Motors AG acquires BUKH A/S – strategic expansion to become the leading supplier for mission-critical defense and marine applications
EQS-News: Steyr Motors AG acquires BUKH A/S – strategic expansion to become the leading supplier for mission-critical defense and marine applications
EQS-Adhoc: Steyr Motors AG resolves to acquire BUKH A/S
EQS-Adhoc: Steyr Motors AG resolves to acquire BUKH A/S
EQS-News: DRIFT Energy chooses Enapter’s AEM electrolyzers for its energy-harvesting sailing vessels
EQS-News: DRIFT Energy chooses Enapter’s AEM electrolyzers for its energy-harvesting sailing vessels
EQS-Adhoc: IVU Traffic Technologies AG: Preliminary financial figures 2025 – IVU again on record course – special dividend proposed
EQS-Adhoc: IVU Traffic Technologies AG: Preliminary financial figures 2025 – IVU again on record course – special dividend proposed
EQS-News: Steyr Motors: Earnings Call Invitation on the Publication of the FY 2025 Annual Report on Friday, March 6, 2026, at 9:00 (CET)
EQS-News: Steyr Motors: Earnings Call Invitation on the Publication of the FY 2025 Annual Report on Friday, March 6, 2026, at 9:00 (CET)
EQS-News: Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory
EQS-News: Darwin AG Announces Preliminary Group Revenue for 2025 and Confirms Strategic Growth Trajectory
EQS-Adhoc: Wolford AG: Marco Pozzo to become CEO and Chairman of the Management Board
EQS-Adhoc: Wolford AG: Marco Pozzo to become CEO and Chairman of the Management Board
EQS-News: Bardahl selects Intershop to unify global B2B commerce operations
EQS-News: Bardahl selects Intershop to unify global B2B commerce operations
EQS-News: From deal to discovery: Gold Hunter now focusing on Great Northern project after CAD 48 million success!
EQS-News: From deal to discovery: Gold Hunter now focusing on Great Northern project after CAD 48 million success!
EQS-News: Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program
EQS-News: Pentixapharm Receives FDA “Study May Proceed” Letters for Dual Theranostic INDs in CXCR4-Based Hemato-Oncology Program
EQS-News: JOST Werke SE: JOST determines number of new shares and placement price
EQS-News: JOST Werke SE: JOST determines number of new shares and placement price
Proposed US$ 100 million credit facility from KfW IPEX-Bank
Proposed US$ 100 million credit facility from KfW IPEX-Bank
EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
EQS-News: BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
EQS-News: EVN AG: Business development in the first quarter of 2025/26
EQS-News: EVN AG: Business development in the first quarter of 2025/26
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Leclanché Appoints Jens Emrich as Chief Financial Officer
Leclanché Appoints Jens Emrich as Chief Financial Officer
EQS-News: Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)
EQS-News: Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab)
EQS-News: MAX Automation SE: Changes to the Supervisory Board and Managing Directorate
EQS-News: MAX Automation SE: Changes to the Supervisory Board and Managing Directorate
EQS-Adhoc: MAX Automation SE: Oliver Jaster appointed Managing Director
EQS-Adhoc: MAX Automation SE: Oliver Jaster appointed Managing Director
EQS-News: HENSOLDT extends CEO Oliver Dörre's contract until end of 2031
EQS-News: HENSOLDT extends CEO Oliver Dörre's contract until end of 2031
EQS-Adhoc: JOST Werke SE: JOST launches a cash capital increase
EQS-Adhoc: JOST Werke SE: JOST launches a cash capital increase